6-110358226-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001123364.3(METTL24):c.47G>T(p.Arg16Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000525 in 1,486,256 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001123364.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
METTL24 | NM_001123364.3 | c.47G>T | p.Arg16Leu | missense_variant | 1/5 | ENST00000338882.5 | |
METTL24 | NM_001354594.2 | c.-405G>T | 5_prime_UTR_variant | 1/4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
METTL24 | ENST00000338882.5 | c.47G>T | p.Arg16Leu | missense_variant | 1/5 | 5 | NM_001123364.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000283 AC: 43AN: 151702Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000338 AC: 3AN: 88808Hom.: 0 AF XY: 0.0000198 AC XY: 1AN XY: 50584
GnomAD4 exome AF: 0.0000270 AC: 36AN: 1334446Hom.: 0 Cov.: 33 AF XY: 0.0000304 AC XY: 20AN XY: 658588
GnomAD4 genome AF: 0.000277 AC: 42AN: 151810Hom.: 0 Cov.: 32 AF XY: 0.000229 AC XY: 17AN XY: 74180
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 14, 2023 | The c.47G>T (p.R16L) alteration is located in exon 1 (coding exon 1) of the METTL24 gene. This alteration results from a G to T substitution at nucleotide position 47, causing the arginine (R) at amino acid position 16 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at